Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
Parallel pattern is coming: Sodium battery cost expected to catch up with lithium battery this year. Material shortages may affect production.
Hong Kong Stock Market New Account Opening Regulations and Their Market Impact? Here are the key points
J.P. Morgan frontline research: The "profitable moment" of Chinese AI has arrived, and the value of the workflow layer is beginning to surpass basic models.
Parallel pattern is coming: Sodium battery cost expected to catch up with lithium battery this year. Material shortages may affect production.
Hong Kong Stock Market New Account Opening Regulations and Their Market Impact? Here are the key points
J.P. Morgan frontline research: The "profitable moment" of Chinese AI has arrived, and the value of the workflow layer is beginning to surpass basic models.
